Hemoadsorption in ‘Liver Indication’—Analysis of 109 Patients’ Data from the CytoSorb International Registry
Background: Our aim is to report the results of the ‘liver indication’ subset of patients in the CytoSorb International Registry. Methods: Structured data were recorded. Treatment characteristics and changes from T1 (start of hemoadsorption) to T2 (termination) were evaluated with a special focus on...
Guardado en:
Autores principales: | Klementina Ocskay, Dana Tomescu, Andreas Faltlhauser, David Jacob, Sigrun Friesecke, Manu Malbrain, Klaus Kogelmann, Ralph Bogdanski, Friedhelm Bach, Harald Fritz, Andreas Hartjes, Andreas Kortgen, Jens Soukup, Stefan Utzolino, Martijn van Tellingen, Karl Träger, Ulrike Schumacher, Frank M. Brunkhorst, Zsolt Molnar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1486c285076b4b99b913684ec5136c25 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Extracorporeal Cytokine Removal in Critically Ill COVID-19 Patients: A Case Series
por: Marcell Virág, et al.
Publicado: (2021) -
Pharmacokinetics of anti-infective agents during CytoSorb hemoadsorption
por: Antoine G. Schneider, et al.
Publicado: (2021) -
Journal of hepatology the journal of the European Association for the Study of the Liver.
Publicado: (1985) - Clinical and experimental hepatology
- Case reports in hepatology